Two Sigma Investments’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Sell |
1,613,225
-461,874
| -22% | -$522K | ﹤0.01% | 1857 |
|
|
2025
Q1 | $3.03M | Sell |
2,075,099
-637,040
| -23% | -$930K | 0.01% | 1410 |
|
|
2024
Q4 | $5.78M | Sell |
2,712,139
-85,831
| -3% | -$183K | 0.01% | 973 |
|
|
2024
Q3 | $7.83M | Sell |
2,797,970
-162,703
| -5% | -$456K | 0.02% | 822 |
|
|
2024
Q2 | $6.9M | Buy |
2,960,673
+1,049,335
| +55% | +$2.44M | 0.02% | 818 |
|
|
2024
Q1 | $8.54M | Sell |
1,911,338
-403,203
| -17% | -$1.8M | 0.02% | 672 |
|
|
2023
Q4 | $7.43M | Buy |
2,314,541
+1,014,320
| +78% | +$3.26M | 0.02% | 751 |
|
|
2023
Q3 | $4.12M | Sell |
1,300,221
-652,559
| -33% | -$2.07M | 0.01% | 941 |
|
|
2023
Q2 | $9.71M | Buy |
1,952,780
+76,031
| +4% | +$378K | 0.02% | 612 |
|
|
2023
Q1 | $9.27M | Buy |
1,876,749
+265,497
| +16% | +$1.31M | 0.03% | 585 |
|
|
2022
Q4 | $10.1M | Buy |
1,611,252
+778,288
| +93% | +$4.9M | 0.03% | 525 |
|
|
2022
Q3 | $9M | Buy |
832,964
+673,886
| +424% | +$7.28M | 0.03% | 509 |
|
|
2022
Q2 | $1.81M | Sell |
159,078
-795,086
| -83% | -$9.06M | 0.01% | 1205 |
|
|
2022
Q1 | $8.69M | Buy |
954,164
+764,373
| +403% | +$6.96M | 0.03% | 647 |
|
|
2021
Q4 | $2.83M | Buy |
+189,791
| New | +$2.83M | 0.01% | 1163 |
|
|
2021
Q3 | – | Sell |
-31,359
| Closed | -$818K | – | 2492 |
|
|
2021
Q2 | $818K | Sell |
31,359
-161,179
| -84% | -$4.2M | ﹤0.01% | 1773 |
|
|
2021
Q1 | $6.8M | Sell |
192,538
-151,086
| -44% | -$5.33M | 0.02% | 718 |
|
|
2020
Q4 | $8.67M | Sell |
343,624
-21,024
| -6% | -$531K | 0.02% | 550 |
|
|
2020
Q3 | $13.8M | Buy |
364,648
+111,255
| +44% | +$4.2M | 0.05% | 349 |
|
|
2020
Q2 | $10.9M | Buy |
+253,393
| New | +$10.9M | 0.05% | 323 |
|